Origent’s Chief Science Officer Dr. David Ennist today conducted a webinar discussion to the ALS Association, titled “How Can We Use Predictions of Individual ALS Patient Disease Progressions to Improve ALS Clinical Trials?” The webinar discussed how human clinical trials can leverage patient-level predictive models to be run more efficiently and with greater potential for demonstrating successful clinical endpoints.

The webinar was conducted at 4:00 PM Eastern U.S. time on January 19, 2016.  The recorded webinar can be viewed at the ALS Association website.

Share This